Keep the semaglutide in its original packaging
J Pharm Sci 95:25432552 Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept
Some people may notice a decrease in appetite shortly after their first dose, for others, it can take a bit longer (a week or two)
We comply with all relevant privacy laws, such as AVG, and ensure that your data is stored securely